Serum levels of monocyte chemoattractant protein-1 in periodontal health and disease

Cytokine

Volumn 47, Issue 2, 2009, Pages 77-81

  Pradeep, A R ^a   Daisy, Happy ^a   Hadge, Parag ^a  

^a Research Institute   (India)

Author keywords

Chronic periodontitis; Monocyte chemoattractant protein 1; Scaling and root planing; Serum

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GINGIVITIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERIODONTAL DISEASE; PERIODONTITIS; PREVENTIVE DENTISTRY; PRIORITY JOURNAL;

ADULT; CHEMOKINE CCL2; CHRONIC PERIODONTITIS; FEMALE; GINGIVITIS; HUMANS; MALE; PERIODONTIUM;

EID: 67650621558     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.05.012     Document Type: Article

References (47)

1. Loe H., Teilade E., and Jensen S.B. Experimental gingivitis in man. J Periodontol 36 (1965) 177-187
2. Genco R.J. Host responses in periodontal diseases: current concepts. J Periodontol 63 (1992) 338-355
3. Ebersole J.L. Humoral immune responses in gingival crevice fluid: local and systemic implications. Periodontol-2000 31 (2003) 135-166
4. Ebersole J.L., Machen R.L., Steffen M.J., and Willmann D.E. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 107 (1997) 347-352
5. Loos B.G., Craandijk J., Hoek F.J., Wertheim-van Dillen P.M., and van der Velden V. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71 (2000) 1528-1534
6. Beck J.D., and Offenbacher S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 76 (2005) 2089-2100
7. Sanchez A.R., Kupp L.I., Sheridan P.J., and Sanchez D.R. Maternal chronic infection as a risk factor in preterm low birth weight infants: the link with periodontal infection. J Int Acad Periodontol 6 (2004) 89-94
8. Iacopino A.M. Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol 6 (2001) 125-137
9. Katancik J.A., Kritchevsky S., Weyant R.J., Corby P., Bretz W., Crapo R.O., et al. Periodontitis and airway obstruction. J Periodontol 76 (2005) 2161-2167
10. Ward S.G., Bacon K., and Westwick J. Chemokines and T lymphocytes: more than attraction. Immunity 9 (1998) 1-11
11. Miller M.D., and Krangel M.S. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12 (1992) 17-46
12. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 18 (2000) 217-242
13. Matsushima K., Larsen C.G., DuBois G.C., and Oppenheim J.J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169 (1989) 1485-1490
14. Yoshimura T., and Leonard E.J. Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. J Immunol 145 (1990) 292-297
15. Colotta F., Borrè A., Wang J.M., Tattanelli M., Maddalena F., Polentarutti N., et al. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol 148 (1992) 760-765
16. Van Damme J., Proost P., Put W., Arens S., Lenaerts J.P., Conings R., et al. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J Immunol 152 (1994) 5495-5502
17. Yu X.H., Antoniades H., and Graves D. Expression of monocyte-chemoattractant protein-1 in human inflamed gingival tissues. Infect Immun 61 (1993) 4622-4628
18. Ozaki K., Hanazawa S., Takeshita A., Chen Y., Watanabe A., Nishida K., et al. Interleukin-1β and tumor necrosis factor-alpha stimulate synergistically the expression of monocyte chemoattractant protein-1 in fibroblastic cells derived from human periodontal ligament. Oral Microbiol Immunol 11 2 (1996) 109-114
19. Valente A.J., Graves D.T., Vialle-Valentin C.E., Delgado R., and Schwartz C.J. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27 (1988) 4162-4168
20. Jiang Y., Beller D., Frendl G., and Graves D. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 148 (1992) 2423-2428
21. Rollins B.J., and Sunday M.E. Suppression of tumor formation in vivo by expression of the IE gene in malignant cells. Mol Cell Biol 11 (1991) 3125-3131
22. Tonetti M.S., Imboden M.A., Gerber L., Lang N.P., Laissue J., and Mueller C. Localized expression of mRNA for phagocytic specific chemotactic cytokines in human periodontal infections. Infect Immun 62 (1994) 4005-4014
23. Emingil G., Atilla G., and Huseyinov A. Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol 31 (2004) 829-834
24. Kurtis B., Tuter G., Serdar M., Akdemir P., Uygur C., Firatli E., et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 76 (2005) 1849-1855
25. Nelken N.A., Coughlin S.R., Gordon D., and Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88 (1991) 1121-1127
26. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., et al. Overexpression of MCP-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281 36 (2006) 26602-26614
27. Antoniades H.N., Neville-Golden J., Galanopoulos T., Kradin R.L., Valente A.J., and Graves D.T. Expression of monocyte chemoattractant protein-1 in mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 89 (1992) 5371-5375
28. Graves D.T., Barnhill R., Galanopoulos T., and Antoniades H.N. Expression of monocyte chemoattractant protein-1 inhuman melanoma in vivo. Am J Pathol 140 (1992) 9-14
29. Villiger P.M., Terkeltaub R., and Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 149 (1992) 722-727
30. Yu X., Barnhill R.T., and Graves D.T. Expression of monocyte chemoattractant protein-1 (MCP-1) in delayed type hypersensitivity reactions in the skin. Lab Invest 71 (1994) 235-266
31. Page R.C. Periodontal diseases: a new paradigm. J Dent Educ 62 (1998) 812-821
32. Khocht A., Janal M., Harasty L., and Minchang K. Comparison of direct digital and conventional intraoral radiographs in detecting alveolar bone loss. JADA 134 (2003) 1468-1475
33. Loe H., and Silness J. Periodontal disease in pregnancy. I prevalence and severity. Acta Odontol Scand 21 (1963) 533
34. Kinane D.F., and Lindhe J. Chronic periodontitis. In: Lindhe J., Karring T., and Lang N.P. (Eds). Clinical periodontology and imolant dentistry. 4th ed. (2003), Blackwell, Oxford 209-215
35. Hanazawa S., Kawata Y., Takeshita A., Kumada H., Okithu M., Tanaka S., et al. Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 61 (1993) 5219-5224
36. Milward M.R., Chapple I.L.C., Wright H.J., Millard J.L., Matthews J.B., and Cooper P.R. Differential activation of NF-kB and gene expression in oral epithelial cells by periodontal pathogens. Clin Exp Immunol 148 (2007) 307-324
37. Jiang Y., and Graves D.T. Periodontal pathogens stimulate CC-chemokine production by mononuclear and bone derived cells. J Periodontol 70 (1999) 1472-1478
38. Baker P.J. The role of immune responses in bone loss during periodontal disease. Microbes Infect 2 (2000) 1181-1192
39. Non-surgical periodontal treatment: consensus statement. In: Proceedings of the world workshop in clinical periodontics. Chicago: American Academy of Periodontology; 1989:II-13-II-17.
40. Badersten A., Nilveus R., and Egelberg J. Effect of nonsurgical periodontal therapy, I: moderately advanced periodontitis. J Clin Periodontol 8 1 (1981) 57-72
41. Arakelyan A., Petrkova J., Hermanova Z., Boyajyan A., Lukl J., and Petrek M. Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators Inflamm 3 (2005) 175-179
42. Zhou L., Azfer A., Niu J., Graham S., Choudhury M., Adamski F.M., et al. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ Res 98 (2006) 1177-1185
43. Hartl D., Griese M., Nicolai T., Zissel G., Prell C., Reinhardt D., et al. A role for MCP-1/CCR2 in interstitial lung disease in children. Respir Res 6 (2005) 93-105
44. Scannapieco F.A., Bush R.B., and Paju S. Association between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. J Periodontal 8 (2003) 38-53
45. Gong J.-H., Ratkay L.G., Waterfield J.D., and Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 186 (1997) 131-137
46. Rollins B.J. Monocyte chemoattractant protein-1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2 (1996) 198-204
47. Egashira K., Koyanagi M., Kitamoto S., Ni W., Kataoka C., Morishita R., et al. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibitor vascular remodeling induced by chronic blockade of NO synthesis. FASEB J 14 (2000) 1974-1978